Results 121 to 130 of about 78,382 (206)

BRAF Inhibitor ARQ 736 [PDF]

, 2020
openaire   +1 more source

Transposon mediated functional genomic screening for BRAF inhibitor resistance reveals convergent Hippo and MAPK pathway activation events. [PDF]

Sci Rep
Chen L, Pruteanu-Malinici I, Dastur A, Yin X, Frederick D, Sadreyev RI, Benes CH.   +6 more
europepmc   +2 more sources

Correction to: BRAF Inhibitor Resistance in Meslanoma: Mechanisms and Alternative Therapeutic Strategies. [PDF]

Curr Treat Options Oncol, 2022
Zhong J, Yan W, Wang C, Liu W, Lin X, Zou Z, Sun W, Chen Y.   +7 more
europepmc   +1 more source

C-Terminal Hsp90 Inhibitors Overcome MEK and BRAF Inhibitor Resistance in Melanoma. [PDF]

J Cell Mol Med
Subramanian C, Hohenberger KK, Zuo A, Cousineau E, Blagg B, Cohen M.   +5 more
europepmc   +1 more source

Targeted BRAF Inhibitor Therapy Induces Remission of Unresectable Ampullary Adenocarcinoma. [PDF]

ACG Case Rep J, 2022
Rego R, Safar A.
europepmc   +1 more source

iASPP suppression mediates terminal UPR and improves BRAF-inhibitor sensitivity of colon cancers. [PDF]

Cell Death Differ, 2023
Zheng S, Wang X, Liu H, Zhao D, Lin Q, Jiang Q, Li L, Hu Y.   +7 more
europepmc   +1 more source

Exploiting mitochondrial dysfunction to overcome BRAF inhibitor resistance in advanced melanoma: the role of disulfiram as a copper ionophore. [PDF]

Cell Death Dis
Zhao B, Ban F, Li Y, Shi Q, Guo S, Yi X, Wang H, Gao T, Li C, Zhu G.   +9 more
europepmc   +1 more source

BRAF inhibitor monotherapy in BRAFV600E-mutated pediatric low-grade glioma: a single center's experience. [PDF]

Front Oncol
McThenia SS, Reddy KM, Damaraju E, Castellino E, He Z, Beers R, Chien F, Castellino RC, Goldman-Yassen AE, Fangusaro JR, MacDonald T.   +10 more
europepmc   +1 more source

Dyslipidemia in Children Treated with a BRAF Inhibitor for Low-Grade Gliomas: A New Side Effect? [PDF]

Cancers (Basel), 2022
Crocco M, Verrico A, Milanaccio C, Piccolo G, De Marco P, Gaggero G, Iurilli V, Di Profio S, Malerba F, Panciroli M, Giordano P, Calevo MG, Casalini E, Di Iorgi N, Garrè ML.   +14 more
europepmc   +1 more source

Proteasomal down-regulation of the proapoptotic MST2 pathway contributes to BRAF inhibitor resistance in melanoma. [PDF]

Life Sci Alliance, 2022
Romano D, García-Gutiérrez L, Aboud N, Duffy DJ, Flaherty KT, Frederick DT, Kolch W, Matallanas D.   +7 more
europepmc   +1 more source